vs
KESTRA MEDICAL TECHNOLOGIES, LTD.(KMTS)与WEST BANCORPORATION INC(WTBA)财务数据对比。点击上方公司名可切换其他公司
WEST BANCORPORATION INC的季度营收约是KESTRA MEDICAL TECHNOLOGIES, LTD.的1.2倍($26.9M vs $22.6M),WEST BANCORPORATION INC净利率更高(39.2% vs -145.3%,领先184.5%),WEST BANCORPORATION INC自由现金流更多($12.4M vs $-25.6M)
Kestra Medical Technologies(KMTS)是一家专注于微创医疗器械研发、生产与商业化的医疗科技企业,核心产品覆盖介入心脏病学与结构性心脏病治疗领域,市场覆盖北美、欧洲及亚太重点区域,服务全球医疗机构与患者。
West Bancorporation Inc.是总部位于美国中西部的区域性金融控股公司,主要服务爱荷华州、明尼苏达州两地市场,面向不同群体提供多元化个人及商业银行服务,包括存款账户、按揭贷款、企业信贷、财富管理等专业解决方案,覆盖个人客户、中小企业及本地机构客户。
KMTS vs WTBA — 直观对比
营收规模更大
WTBA
是对方的1.2倍
$22.6M
净利率更高
WTBA
高出184.5%
-145.3%
自由现金流更多
WTBA
多$38.0M
$-25.6M
损益表 — Q2 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $22.6M | $26.9M |
| 净利润 | $-32.8M | $10.6M |
| 毛利率 | 50.6% | — |
| 营业利润率 | -140.7% | 50.0% |
| 净利率 | -145.3% | 39.2% |
| 营收同比 | — | 16.6% |
| 净利润同比 | — | 34.8% |
| 每股收益(稀释后) | $-0.64 | $0.61 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
KMTS
WTBA
| Q1 26 | — | $26.9M | ||
| Q4 25 | $22.6M | $24.2M | ||
| Q3 25 | $19.4M | $25.0M | ||
| Q2 25 | — | $23.8M | ||
| Q1 25 | — | $23.1M | ||
| Q4 24 | — | $20.9M | ||
| Q3 24 | — | $20.3M | ||
| Q2 24 | — | $19.6M |
净利润
KMTS
WTBA
| Q1 26 | — | $10.6M | ||
| Q4 25 | $-32.8M | $7.4M | ||
| Q3 25 | $-25.8M | $9.3M | ||
| Q2 25 | — | $8.0M | ||
| Q1 25 | — | $7.8M | ||
| Q4 24 | — | $7.1M | ||
| Q3 24 | — | $6.0M | ||
| Q2 24 | — | $5.2M |
毛利率
KMTS
WTBA
| Q1 26 | — | — | ||
| Q4 25 | 50.6% | — | ||
| Q3 25 | 45.7% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
营业利润率
KMTS
WTBA
| Q1 26 | — | 50.0% | ||
| Q4 25 | -140.7% | 39.6% | ||
| Q3 25 | -149.1% | 45.8% | ||
| Q2 25 | — | 43.4% | ||
| Q1 25 | — | 43.4% | ||
| Q4 24 | — | 30.9% | ||
| Q3 24 | — | 36.6% | ||
| Q2 24 | — | 32.6% |
净利率
KMTS
WTBA
| Q1 26 | — | 39.2% | ||
| Q4 25 | -145.3% | 30.7% | ||
| Q3 25 | -133.3% | 37.3% | ||
| Q2 25 | — | 33.5% | ||
| Q1 25 | — | 34.0% | ||
| Q4 24 | — | 34.0% | ||
| Q3 24 | — | 29.3% | ||
| Q2 24 | — | 26.5% |
每股收益(稀释后)
KMTS
WTBA
| Q1 26 | — | $0.61 | ||
| Q4 25 | $-0.64 | $0.44 | ||
| Q3 25 | $-0.50 | $0.55 | ||
| Q2 25 | — | $0.47 | ||
| Q1 25 | — | $0.46 | ||
| Q4 24 | — | $0.41 | ||
| Q3 24 | — | $0.35 | ||
| Q2 24 | — | $0.31 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $175.4M | $362.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $164.1M | $270.7M |
| 总资产 | $246.7M | $4.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
KMTS
WTBA
| Q1 26 | — | $362.0M | ||
| Q4 25 | $175.4M | $471.1M | ||
| Q3 25 | $201.2M | $232.9M | ||
| Q2 25 | — | $345.2M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $243.5M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益
KMTS
WTBA
| Q1 26 | — | $270.7M | ||
| Q4 25 | $164.1M | $266.0M | ||
| Q3 25 | $184.2M | $255.1M | ||
| Q2 25 | — | $240.9M | ||
| Q1 25 | — | $237.9M | ||
| Q4 24 | — | $227.9M | ||
| Q3 24 | — | $235.4M | ||
| Q2 24 | — | $223.9M |
总资产
KMTS
WTBA
| Q1 26 | — | $4.0B | ||
| Q4 25 | $246.7M | $4.1B | ||
| Q3 25 | $266.3M | $4.0B | ||
| Q2 25 | — | $4.1B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | — | $4.0B | ||
| Q3 24 | — | $4.0B | ||
| Q2 24 | — | $4.0B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-18.3M | $12.9M |
| 自由现金流经营现金流 - 资本支出 | $-25.6M | $12.4M |
| 自由现金流率自由现金流/营收 | -113.5% | 46.0% |
| 资本支出强度资本支出/营收 | 32.2% | 1.8% |
| 现金转化率经营现金流/净利润 | — | 1.22× |
| 过去12个月自由现金流最近4个季度 | — | $79.1M |
8季度趋势,按日历期对齐
经营现金流
KMTS
WTBA
| Q1 26 | — | $12.9M | ||
| Q4 25 | $-18.3M | $46.5M | ||
| Q3 25 | $-26.3M | $11.4M | ||
| Q2 25 | — | $13.5M | ||
| Q1 25 | — | $9.7M | ||
| Q4 24 | — | $39.8M | ||
| Q3 24 | — | $12.9M | ||
| Q2 24 | — | $10.0M |
自由现金流
KMTS
WTBA
| Q1 26 | — | $12.4M | ||
| Q4 25 | $-25.6M | $43.2M | ||
| Q3 25 | $-34.4M | $10.8M | ||
| Q2 25 | — | $12.8M | ||
| Q1 25 | — | $8.3M | ||
| Q4 24 | — | $13.7M | ||
| Q3 24 | — | $7.0M | ||
| Q2 24 | — | $2.7M |
自由现金流率
KMTS
WTBA
| Q1 26 | — | 46.0% | ||
| Q4 25 | -113.5% | 178.3% | ||
| Q3 25 | -177.8% | 43.0% | ||
| Q2 25 | — | 53.6% | ||
| Q1 25 | — | 35.7% | ||
| Q4 24 | — | 65.6% | ||
| Q3 24 | — | 34.2% | ||
| Q2 24 | — | 14.0% |
资本支出强度
KMTS
WTBA
| Q1 26 | — | 1.8% | ||
| Q4 25 | 32.2% | 13.7% | ||
| Q3 25 | 42.2% | 2.6% | ||
| Q2 25 | — | 3.2% | ||
| Q1 25 | — | 6.5% | ||
| Q4 24 | — | 125.3% | ||
| Q3 24 | — | 29.4% | ||
| Q2 24 | — | 37.1% |
现金转化率
KMTS
WTBA
| Q1 26 | — | 1.22× | ||
| Q4 25 | — | 6.26× | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 1.70× | ||
| Q1 25 | — | 1.24× | ||
| Q4 24 | — | 5.61× | ||
| Q3 24 | — | 2.17× | ||
| Q2 24 | — | 1.93× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图